Scharf Stefanie, Zahlten Janine, Szymanski Kolja, Hippenstiel Stefan, Suttorp Norbert, N'Guessan Philippe Dje
Department of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Exp Lung Res. 2012 Mar;38(2):100-10. doi: 10.3109/01902148.2011.652802.
Streptococcus pneumoniae is an important causative agent of pneumonia in humans. Pulmonary epithelial surfaces constitutes not only a mechanical barrier against invading pathogens but also essentially contribute to innate immunity by producing antimicrobial peptides such as human β-defensin-2 (hBD-2) and -3 (hBD-3). In this study the authors demonstrated that pneumococci induced hBD-2 and hBD-3 expression in human pulmonary epithelial cells. Further analysis indicated an essential role of Toll-like receptor 2 (TLR2) for the expression of both peptides in infected pulmonary epithelial cells. Whereas the hBD-2 release was controlled by the phosphoinositide 3-kinase (PI3K) and the transcription factor nuclear factor kappa B (NF-κB), hBD-3 was triggered via the c-Jun N-terminal kinase (JNK)-activator protein 1 (AP-1) pathway. Additionally, the authors showed that exogenous hBD-2 as well as hBD-3 elicited a strong antimicrobial effect on S. pneumoniae. Thus, differential regulation of the expression of hBD-2 and hBD-3 might play an important role in pneumococci pneumonia.
肺炎链球菌是人类肺炎的重要病原体。肺上皮表面不仅构成抵御入侵病原体的机械屏障,还通过产生如人β-防御素-2(hBD-2)和-3(hBD-3)等抗菌肽对固有免疫起重要作用。在本研究中,作者证明肺炎球菌可诱导人肺上皮细胞中hBD-2和hBD-3的表达。进一步分析表明,Toll样受体2(TLR2)在感染的肺上皮细胞中对这两种肽的表达起关键作用。hBD-2的释放受磷酸肌醇3-激酶(PI3K)和转录因子核因子κB(NF-κB)调控,而hBD-3则通过c-Jun氨基末端激酶(JNK)-激活蛋白1(AP-1)途径触发。此外,作者表明外源性hBD-2和hBD-3对肺炎链球菌均有强大的抗菌作用。因此,hBD-2和hBD-3表达的差异调节可能在肺炎球菌肺炎中起重要作用。